Clearmind Medicine Inc. (Nasdaq, CSE: CMND / FSE: CWY) a biotech company focused on discovery and development of novel psychedelic-derived therapeutics...
PharmAla Biotech Holdings Inc. (CSE: MDMA / OTC: PMBHF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX...
PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA The post PharmaTher Initiates Filing of Abbreviated...
FSD Pharma (NASDAQ: HUGE / CSE: HUGE), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the...
Mindset Pharma has been granted approval to start a Phase 2 trial for Major Depressive Disorder, using their lead drug candidate MSP-1014 The post Mindset...
In clinical settings, a racemic mixture of both R and S ketamine is commonly used The post PharmaTher Holdings enters collaboration to commercialize racemic...
Pharmather has announced a collaboration agreement with Vitruvias Therapeutics for the commercialization of its KETARX (racemic ketamine) products in the...
Source: Streetwise Reports 06/16/2023 Algernon Neuro has completed the third stage of its dosage trial for DMT as a treatment for traumatic...
Gotham Green got the placement after buying stock in the offering. The post Psyched Wellness Names Gotham Green Board Member appeared first on Green Market...
PharmAla Psychedelic drug company PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: PMBHF) announced a non-brokered private placement of a minimum 3,333,333...